| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3435392 | American Journal of Obstetrics and Gynecology | 2010 | 7 Pages |
Abstract
Universal prenatal screening for SMA is not cost-effective. For populations at high risk, such as those with a family history, SMA testing may be a cost-effective strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sarah E. MD, Vanitha MD, Anjali MD, MAS, Thomas MD, Jeffrey MD, Aaron B. MD, PhD,